Difference between revisions of "Team:Marburg/Labbook/Minicells"
| Line 433: | Line 433: | ||
<p> | <p> | ||
| − | Cultures containing a plasmid which encodes enzymes for the biosynthesis of β-carotene (Car) were treated according to the | + | Cultures containing a plasmid which encodes enzymes for the biosynthesis of β-carotene (Car) were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol16">Transformation into chemocompetent (RbCl) cells protocol</a>. |
</p> | </p> | ||
| Line 441: | Line 441: | ||
<p> | <p> | ||
| − | Carotinoid plasmids were transformed into chemocompetent TB43 and TB43 HU-mCherry according to Transformation into chemocompetent (RbCl) | + | Carotinoid plasmids were transformed into chemocompetent TB43 and TB43 HU-mCherry according to <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol16">Transformation into chemocompetent (RbCl) cells protocol</a>. |
</p> | </p> | ||
| Line 447: | Line 447: | ||
<p> | <p> | ||
| − | Cultures containing a plasmid which encodes enzymes for the biosynthesis of violacein were treated according to the Macherey-Nagel Plasmid DNA Purification | + | Cultures containing a plasmid which encodes enzymes for the biosynthesis of violacein were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol11">Macherey-Nagel Plasmid DNA Purification protocol</a>. |
</p> | </p> | ||
| Line 463: | Line 463: | ||
<p> | <p> | ||
| − | ONC were treated according to the Macherey-Nagel Plasmid DNA Purification | + | ONC were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol11">Macherey-Nagel Plasmid DNA Purification protocol</a>. |
</p> | </p> | ||
| Line 515: | Line 515: | ||
<p> | <p> | ||
| − | The cultures containing the constructs AL11 (GFP & Amp-resistance) and AL13 (RFP & Amp-resistance) were treated according to Macherey-Nagel Plasmid DNA Purification | + | The cultures containing the constructs AL11 (GFP & Amp-resistance) and AL13 (RFP & Amp-resistance) were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol11">Macherey-Nagel Plasmid DNA Purification protocol</a>. |
</p> | </p> | ||
| Line 523: | Line 523: | ||
<p> | <p> | ||
| − | Cultures with a deletion of the MinC gene were treated according to Macherey-Nagel Plasmid DNA Purification | + | Cultures with a deletion of the MinC gene were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol11">Macherey-Nagel Plasmid DNA Purification protocol</a>. |
</p> | </p> | ||
| Line 535: | Line 535: | ||
<p> | <p> | ||
| − | The PCR product was cleaned according to modified gel extraction protocol. | + | The PCR product was cleaned according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol12">modified gel extraction protocol</a>. |
</p> | </p> | ||
| Line 549: | Line 549: | ||
<p> | <p> | ||
| − | ONC from 15/09/08 were treated according to competent <i>E.coli</i> cells (Electroporation) protocol. | + | ONC from 15/09/08 were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol2">competent <i>E.coli</i> cells (Electroporation) protocol</a>. |
</p> | </p> | ||
| Line 555: | Line 555: | ||
<p> | <p> | ||
| − | All fluorescent protein producing plasmids (both, inducible and constitutive promoters) were transformed into minicell producing strains according to according to | + | All fluorescent protein producing plasmids (both, inducible and constitutive promoters) were transformed into minicell producing strains according to according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol17">Transformation into electrocompetent cells protocol</a>. |
</p> | </p> | ||
| Line 569: | Line 569: | ||
<p> | <p> | ||
| − | The primers iMC1 and iMC2 were used. The product was cleaned up according to the modified gel extraction protocol. | + | The primers iMC1 and iMC2 were used. The product was cleaned up according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol12">modified gel extraction protocol</a>. |
</p> | </p> | ||
| Line 575: | Line 575: | ||
<p> | <p> | ||
| − | The primers iMC3 and iILS5 were used. The product was cleaned up according to the modified gel extraction protocol. | + | The primers iMC3 and iILS5 were used. The product was cleaned up according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol12">modified gel extraction protocol</a>. |
</p> | </p> | ||
| Line 581: | Line 581: | ||
<p> | <p> | ||
| − | A construct for the production of a sRNA was built according to the standard CPEC protocol. | + | A construct for the production of a sRNA was built according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol5">standard CPEC protocol</a>. |
</p> | </p> | ||
| Line 595: | Line 595: | ||
<p> | <p> | ||
| − | Cultures containing the constructs pAB.001 and M13K07 were treated according to Macherey-Nagel Plasmid DNA Purification Kit protocol. | + | Cultures containing the constructs pAB.001 and M13K07 were treated according to the <a href="https://2015.igem.org/Team:Marburg/Protocols/Protocol11">Macherey-Nagel Plasmid DNA Purification Kit protocol</a>. |
</p> | </p> | ||
Revision as of 21:09, 13 September 2015
15/07/07
Preparation of ONCs
Two times 5 mL LB were inoculated with TB43 and TB43 HU-mCherry and incubated at 37 °C and 200 rpm.
15/07/08
Preparation of Glycerol Stocks
Glycerol stocks of TB43 and TB43 HU-mCherry were prepared according to the glycerol stock generation protocol.
Preparation of electrocompetent Cells
Electrocompetent cells of TB43 and TB43 HU-mCherry were prepared according to the electrocompetent E.coli cells protocol.
Preparation of over-night culture (ONC)
Two times 5 mL LB were inoculated with TB43 and TB43 HU-mCherry and incubated at 37 °C and 200 rpm.
15/07/09
Preparation of electrocompetent Cells
Electrocompetent cells of TB43 and TB43 HU-mCherry were prepared according to the electrocompetent E.coli cells protocol.
15/07/10
Preparation of day culture
20 mL LB were inoculated with TB43 and TB43 HU-mCherry for flow cytometry and grown to an optical density (OD) of 0.5. No minicells could be detected.
15/07/11
Transformation
A GFP plasmid with Chloramphenicol resistance gene was transformed into TB43 and TB43 HU-mCherry via electroporation according to the Transformation into electrocompetent cells protocol.
15/07/13
Preparation of ONC
50 mL LB were inoculated with TB43 GFP and TB43 HU-mCherry GFP and incubated at 37 °C and 200 rpm.
15/07/15
Preparation of Minicells
TB43 GFP and TB43 HU-mCherry GFP were treated according to the Preparation of Mini Cells protocol. Samples were taken and minicells could be detected via flow cytometry but only with very low yields.
15/07/27
Preparation of ONC
5 mL LB were inoculated with TB43, TB43 HU-mCherry, TB43 GFP and TB43 HU-mCherry GFP and incubated at 37 °C and 200 rpm.
15/07/28
Preparation of chemocompetent Cells
Chemocompetent cells of TB43, TB43 GFP, TB43 HU-mCherry and TB43 HU-mCherry GFP were prepared according to the competent E.coli cells (RbCl) protocol.
15/08/21
Preparation of ONC
5 mL LB were inoculated with TB43, TB43 HU-mCherry, TB43 GFP and TB43 HU-mCherry GFP and incubated at 37 °C and 200 rpm.
Preparation of M9 Minimal Medium
Two different M9 minimal media were prepared. Both contained 5x M9 salts, 2 mM MgSO4, 0.1 mM CaCl2 and ddH2O, one additionally 0.4% glucose. The media were sterile filtered.
15/08/24
Plasmid Preparation
Cultures containing a plasmid which encodes enzymes for the biosynthesis of β-carotene (Car) were treated according to the Transformation into chemocompetent (RbCl) cells protocol.
15/08/25
Transformation
Carotinoid plasmids were transformed into chemocompetent TB43 and TB43 HU-mCherry according to Transformation into chemocompetent (RbCl) cells protocol.
Plasmid Preparation
Cultures containing a plasmid which encodes enzymes for the biosynthesis of violacein were treated according to the Macherey-Nagel Plasmid DNA Purification protocol.
15/08/29
Preparation of ONC
Four times 5 mL LB was inoculated with TB43 Car and incubated at 37 °C and 200 rpm.
15/08/30
Plasmid Preparation
ONC were treated according to the Macherey-Nagel Plasmid DNA Purification protocol.
15/09/03
Preparation of ONC
5 mL LB were inoculated with TB43, TB43 GFP, TB43 HU-mCherry, TB43 HU-mCherry GFP and TB43 Car and incubated at 37 °C and 200 rpm.
15/09/04
Preparation of ONC
5 mL M9 minimal medium were inoculated with TB43, TB43 GFP, TB43 HU-mCherry, TB43 HU-mCherry GFP and TB43 Car and incubated at 37 °C and 200 rpm.
15/09/05
Growth Curve
TB43, TB43 HU-mCherry, TB43 GFP and TB43 HU-mCherry GFP were cultivated in LB and M9 minimal medium and grown to an OD of 0.5. No minicells could be detected by flow cytometry.
Preparation of ONC
5 mL LB were inoculated from colonies of the first plate (TB43 and TB43 HU-mCherry) and incubated at 37 °C and 200 rpm.
15/09/06
Growth Curve
The procedure from 15/09/05 was repeated with the same result. The calibration of the side scatter sensor of the flow cytometer appeared to be wrong.
15/09/07
Preparation of ONC
5 mL LB were inoculated with the violacein and β-carotene plasmid containing strains and incubated at 37 °C and 200 rpm.
Plasmid Preparation
The cultures containing the constructs AL11 (GFP & Amp-resistance) and AL13 (RFP & Amp-resistance) were treated according to the Macherey-Nagel Plasmid DNA Purification protocol.
15/09/08
Plasmid Preparation
Cultures with a deletion of the MinC gene were treated according to the Macherey-Nagel Plasmid DNA Purification protocol.
PCR
The backbone pILS was amplified according to Standard PCR protocol. 1 μL template DNA was used.
Gel Extraction
The PCR product was cleaned according to the modified gel extraction protocol.
Preparation of ONC
5 mL LB were inoculated with all previous minicell producing strains (both, with and without additional plasmids).
15/09/09
Preparation of electrocompetent Cells
ONC from 15/09/08 were treated according to the competent E.coli cells (Electroporation) protocol.
Transformation
All fluorescent protein producing plasmids (both, inducible and constitutive promoters) were transformed into minicell producing strains according to according to the Transformation into electrocompetent cells protocol.
Preparation of ONC
5 mL LB were inoculated with AL11 and AL13 for induction assays.
15/09/10
PCR
The primers iMC1 and iMC2 were used. The product was cleaned up according to the modified gel extraction protocol.
PCR
The primers iMC3 and iILS5 were used. The product was cleaned up according to the modified gel extraction protocol.
CPEC
A construct for the production of a sRNA was built according to the standard CPEC protocol.
Microscopy
The ONC were examined via fluorescence microscopy. Minicells could clearly be detected.
15/09/11
Plasmid Preparation
Cultures containing the constructs pAB.001 and M13K07 were treated according to the Macherey-Nagel Plasmid DNA Purification Kit protocol.
Flow Cytometry
ONC of minicell producing strains were examined via flow cytometry. The calibration of the side scatter sensor was still not right but minicells could be identified by comparison with a negative control.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.